IMDERMA LABORATORIES CO., LTD.’s BSL-2 biosafety laboratory has successfully passed the Hsinchu Public Health Bureau’s inspection, receiving official confirmation on October 30, 2024, with no non-compliance issues.

Conducted under Article 28, Paragraph 2 of the Regulations on the Management of Infectious Biological Materials, the inspection evaluated facilities, operations, personnel training, and biosafety protocols. The Bureau praised IMDERMA’s strict compliance and outstanding safety standards, highlighting its exceptional biosafety management and protective measures.

IMDERMA LABORATORIES reaffirms its commitment to biosafety excellence, continuously optimizing laboratory management and safety protocols to uphold the highest standards in biomedical research and safeguard public health.

This achievement reinforces IMDERMA’s leadership in biosafety and strengthens its foundation for future innovations in biotechnology.